Live Breaking News & Updates on Akorn Pharmaceuticals

Stay updated with breaking news from Akorn pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merck has clear vision to eye disease assets with $3B EyeBio buy

Merck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. ....

New Jersey , United States , David Guyer , Tony Adamis , Akorn Pharmaceuticals , Merck Co , Chief Scientific Officer Tony Adamis ,